{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": -3.693935, "regularMarketPrice": 0.146, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.29, "sharesOutstanding": 88660496, "bookValue": 0.998, "fiftyDayAverage": 0.393, "fiftyDayAverageChange": -0.24700001, "fiftyDayAverageChangePercent": -0.62849873, "twoHundredDayAverage": 0.684915, "twoHundredDayAverageChange": -0.53891504, "twoHundredDayAverageChangePercent": -0.7868349, "marketCap": 13858699, "priceToBook": 0.14629258, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1549350000000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "BERGENBIO ASA", "longName": "BerGenBio ASA", "messageBoardId": "finmb_107144331", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": -0.0056000054, "regularMarketTime": 1683895069, "regularMarketDayHigh": 0.146, "regularMarketDayRange": "0.1446 - 0.146", "regularMarketDayLow": 0.1446, "regularMarketVolume": 400, "regularMarketPreviousClose": 0.1516, "bid": 0.146, "ask": 0.1874, "bidSize": 110000, "askSize": 37932, "fullExchangeName": "Frankfurt", "financialCurrency": "NOK", "regularMarketOpen": 0.1446, "averageDailyVolume3Month": 1082, "averageDailyVolume10Day": 5065, "fiftyTwoWeekLowChange": 0.018399999, "fiftyTwoWeekLowChangePercent": 0.14420062, "fiftyTwoWeekRange": "0.1276 - 1.588", "fiftyTwoWeekHighChange": -1.442, "fiftyTwoWeekHighChangePercent": -0.90806043, "fiftyTwoWeekLow": 0.1276, "fiftyTwoWeekHigh": 1.588, "symbol": "7BG.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "M\u00f8llendalsbakken 9", "city": "Bergen", "zip": "5009", "country": "Norway", "phone": "47 53 50 15 64", "website": "https://www.bergenbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase II clinical development that focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and COVID-1. The company is also developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase Ib clinical trial. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.", "fullTimeEmployees": 29, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin  Olin", "age": 53, "title": "Chief Exec. Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 879871, "fmt": "879.87k", "longFmt": "879,871"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rune  Skeie", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 242048, "fmt": "242.05k", "longFmt": "242,048"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. James  Barnes Ph.D.", "title": "Chief Operating Officer", "fiscalYear": 2022, "totalPay": {"raw": 25443, "fmt": "25.44k", "longFmt": "25,443"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nigel  McCracken M.Sc., Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2022, "totalPay": {"raw": 379973, "fmt": "379.97k", "longFmt": "379,973"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Gayle M. Mills M.B.A", "age": 67, "title": "Chief Bus. Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cristina  Oliva M.D.", "title": "Chief Medical Officer", "fiscalYear": 2022, "totalPay": {"raw": 32396, "fmt": "32.4k", "longFmt": "32,396"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Akil  Jackson", "title": "Medical Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}